A judge has expressed frustration at the slow pace of the Sydney light rail class action, forcing both parties to commit to a timetable that will push the proceeding more rapidly towards a final hearing.
The founder of a fintech company suing Visa for allegedly abusing its market dominance is flying a Federal Court judge to the UK to preside over the examination of a key but reluctant witness in the case, former Visa boss Rupert Keeley.
A judge has approved a $2.5 million penalty against two hearing aid retailers in the consumer regulator’s case alleging the companies targeted vulnerable pensioners with misleading newspaper ads.
Judges do not have the power to approve a class action settlement without first issuing an opt-out notice to group members, the court-appointed contradictor in two shareholder class actions against online fashion retailer Surfstitch told the NSW Supreme Court Thursday.
Private education provider Ashley Services may be close to settling a shareholder class action, according to a court order sending the parties in the case to a second mediation session before the end of the year.
Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer’s blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.
Actor Geoffrey Rush is seeking to suppress an amended defence by Nationwide News, arguing that if they’re made public the amendments could cause him “irreparable harm”.
A Federal Court judge has rejected a revised pleading in a class action against Ford over its allegedly defective PowerShift transmissions.
The administrators of collapsed startup Unlockd have withdrawn the company’s case against Google alleging the search engine giant abused its dominance to keep it out of the digital ad market.
Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.